These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 17890728)

  • 21. [The anticoagulant treatment of patients with heart valve prostheses].
    Cristodorescu R; Brânzan L; Szvantek C; Drăgulescu S; Anderca I; Streian C
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(4):343-52. PubMed ID: 2573944
    [No Abstract]   [Full Text] [Related]  

  • 22. Anticoagulation interruptus: not without risk.
    Ezekowitz MD
    Circulation; 2004 Sep; 110(12):1518-9. PubMed ID: 15381656
    [No Abstract]   [Full Text] [Related]  

  • 23. [The management of dental and maxillofacial surgery patients under anticoagulant therapy].
    Hönig JF; Merten HA
    Dtsch Z Mund Kiefer Gesichtschir; 1991; 15(5):334-9. PubMed ID: 1840096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral anticoagulants in patients with mechanical cardiac valve replacement: the role of aspirin.
    Altman R; Rouvier J
    Circulation; 1997 Nov; 96(10):3807-8. PubMed ID: 9396509
    [No Abstract]   [Full Text] [Related]  

  • 25. [Haemorrhagic and thrombo-embolic complications in patients with prosthetic valves--the under-appreciated problem with no safe solutions].
    Trzeciak P; Poloński L; Zembala M
    Kardiol Pol; 2006 Sep; 64(9):1038-42. PubMed ID: 17054041
    [No Abstract]   [Full Text] [Related]  

  • 26. Oral anticoagulation and mechanical heart valves: the case of the elderly and pregnancy.
    Rubboli A; Di Pasquale G
    Ital Heart J; 2005 May; 6(5):405-8. PubMed ID: 15934414
    [No Abstract]   [Full Text] [Related]  

  • 27. Aortic valve replacement: a prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years.
    Stassano P; Di Tommaso L; Monaco M; Iorio F; Pepino P; Spampinato N; Vosa C
    J Am Coll Cardiol; 2009 Nov; 54(20):1862-8. PubMed ID: 19892237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gains and losses during anticoagulation treatment in patients with mechanical heart valves.
    Filippatos GS; Gavrielatos G; Kremastinos DT
    J Intern Med; 2006 Dec; 260(6):595. PubMed ID: 17116013
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term anticoagulation with fondaparinux in a patient with a mechanical heart valve.
    Nagler M; Haslauer M; Wuillemin WA
    Ann Hematol; 2011 Oct; 90(10):1225-6. PubMed ID: 21207030
    [No Abstract]   [Full Text] [Related]  

  • 30. [Anticoagulation therapy in patients with valvular prostheses].
    Chlumský J
    Vnitr Lek; 1994 Dec; 40(12):779-82. PubMed ID: 7839632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-term oral coagulation. Self monitoring prevents complication].
    MMW Fortschr Med; 2003 May; 145(19):53. PubMed ID: 12813982
    [No Abstract]   [Full Text] [Related]  

  • 32. International normalized ratio patient self-management for mechanical valves: is it safe enough?
    Koerfer R; Reiss N; Koertke H
    Curr Opin Cardiol; 2009 Mar; 24(2):130-5. PubMed ID: 19532098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recommendations for endoscopy in the patient on chronic anticoagulation: apply with care!
    Harewood GC
    Gastrointest Endosc; 2006 Jul; 64(1):79-81. PubMed ID: 16813807
    [No Abstract]   [Full Text] [Related]  

  • 34. Conservative approach to dental extractions in patients on anticoagulant therapy: A clinical study.
    Somma F; Grande NM; Plotino G; Cameli G; Pameijer CH
    Gen Dent; 2010; 58(1):e30-5. PubMed ID: 20129880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of thromboembolic complications in patients with mechanical heart valves with a subtherapeutic international normalized ratio.
    Dentali F; Riva N; Malato A; Saccullo G; Siragusa S; Ageno W
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):91-3. PubMed ID: 19154909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subtherapeutic oral anticoagulant therapy: frequency and risk factors.
    Rombouts EK; Rosendaal FR; van der Meer FJ
    Thromb Haemost; 2009 Mar; 101(3):552-6. PubMed ID: 19277419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risks and benefits of anticoagulant therapy.
    Levine MN
    Semin Thromb Hemost; 1986 Jan; 12(1):67-71. PubMed ID: 3961508
    [No Abstract]   [Full Text] [Related]  

  • 38. eComment: Anticoagulation for mechanical heart valves: a current assessment.
    Koniari I
    Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):264-5. PubMed ID: 19164312
    [No Abstract]   [Full Text] [Related]  

  • 39. [Anticoagulation therapy in patients with valve defects].
    Chlumský J; Potuzník P
    Vnitr Lek; 1996 Feb; 42(2):78-81. PubMed ID: 8686194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement.
    Eitz T; Schenk S; Fritzsche D; Bairaktaris A; Wagner O; Koertke H; Koerfer R
    Ann Thorac Surg; 2008 Mar; 85(3):949-54; discussion 955. PubMed ID: 18291177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.